Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2017 Earnings

8NovExpected

Q4 2016

Q1 2017

Q2 2017

Q3 2017

-0.56

-0.53

-0.49

-0.46

Details

Expected EPS

-0.55

Actual EPS

-0.48

Surprise EPS

0.07

Surprise Percent

+12.73%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.48 per share for Q3 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.